Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver function tests: "pugilistic pseudo-relapse"

R L Sham

    American Journal of Hematology
    |September 18, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles.

    Blood·2000
    Same author

    Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.

    American journal of hematology·2000
    Same author

    Hematologic neoplasia and the central nervous system.

    American journal of hematology·1999
    Same author

    Prevalence of hereditary hemochromatosis in 16031 primary care patients.

    Annals of internal medicine·1998
    Same author

    Hepatic iron index: how useful is it?

    Gastroenterology·1998
    Same author

    Disorders that resemble lymphomas.

    American journal of hematology·1997
    Same journal

    Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

    American journal of hematology·2026
    Same journal

    Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B-ALL.

    American journal of hematology·2026
    Same journal

    Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.

    American journal of hematology·2026
    Same journal

    Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

    American journal of hematology·2026
    Same journal

    Safety and Efficacy of Plerixafor in Poor Mobilizers With Lymphoma: A Multicenter, Prospective, Single-Arm Study.

    American journal of hematology·2026
    Same journal

    Dordaviprone Maintenance After Allogeneic HCT for High-Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

    American journal of hematology·2026
    See all related articles